NORTH READING, Mass., Jan. 3, 2019 /PRNewswire/ -- TraceLink Inc., the world's largest integrated digital supply network, providing real-time information sharing for better patient outcomes, today announced that, for the third consecutive year, Shabbir Dahod, president and CEO of TraceLink, will present at the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7 at 5 p.m. PST at the Westin St. Francis in San Francisco.
During his presentation, Dahod will discuss the global market opportunity for TraceLink's digital supply network and its role in creating a patient-centric, information-sharing ecosystem that enables hundreds of thousands of businesses to collaborate on new, innovative digital solutions and maximize the efficacy, quality, safety, security and availability of products that improve human life.
About TraceLink
TraceLink is the world's largest integrated digital supply network, providing real-time information sharing for better patient outcomes. Leading businesses trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. The TraceLink digital supply network is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit www.tracelink.com.
TraceLink is funded by Georgian Partners, Willett Advisors LLC, Vulcan Capital, Goldman Sachs, FirstMark Capital, Volition Capital and F-Prime Capital.
SOURCE TraceLink
